ChIP experiments using chromatin extracted from patient tissue revealed that IRF6 binding to the ISRE site on the IL-1β promoter decreased during CIN severity (Fig 8F), indicating that loss of IRF6 inversely correlates with cervical neoplasia progression. This evidence concerns the gene IRF6 and cervical squamous intraepithelial neoplasia.